Pulmonary Hypertension

12345678910111213141516
Across
  1. 2. Ultimate way to diagnosis PH
  2. 4. IV only prostacyclin medication
  3. 5. CCB not recommended due to potent negative inotropic activity
  4. 8. Type of PH involving left heart disease, usually HFpEF.
  5. 9. Unique adverse effect with Bosentan
  6. 10. Methamphetamines and toxic rapeseed oil association to PAH
  7. 13. PDE-V inhibitor preferred in advanced CKD
  8. 16. Trial for untreated PAH using ambrisentan and tadalafil
Down
  1. 1. PAH risk calculator
  2. 2. Good oral option if PDEi5 have shown no improvement
  3. 3. 2 forms required for females to take Riociguat
  4. 6. Important noninvasive to provide comprehensive information on L/F ventricular anatomy
  5. 7. Type of PH with pulmonary vascular remodeling and increased resistance, usually PAH
  6. 11. PH is characterized by a mPAP greater than
  7. 12. Amount of group classifications of PAH
  8. 13. Drug class used in HF and PH in left heart disease management
  9. 14. Treatment option for CTEPH
  10. 15. Steps to recovery in chronic thromboembolic PH